businesspress24.com - Vista Partners Publishes August 2012 Newsletter
 

Vista Partners Publishes August 2012 Newsletter

ID: 1138967

Topics Include: Monthly Macroeconomic Commentary, Olympics, Facebook, Portfolio Company Ideas & More

(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 08/02/12 -- ("Vista") announced today that it published its FREE macroeconomic/small cap oriented monthly newsletter for the month of August. Each monthly newsletter from Vista contains macroeconomic thoughts from Principal Analyst, Ross Silver, and monthly highlights of each covered small cap company.

Ross Silver, Principal Analyst at Vista Partners, stated in the newsletter, "For those of you who profited from Facebook being a great short idea (), congratulations and there may be more downside." Mr. Silver goes on to state, "Many investors have been playing the dividend game by parking money into companies who have dividends higher than the risk free rate and a track record of raising dividends. The thought behind this strategy is to park money in a company with a history of dividend increases and low volatility and get a potential bonus should the equity increase in value."

Some potential catalysts from our portfolio companies:

ADVENTRX (ticker: ANX) initiating their planned Phase 3 trial in sickle cell disease

Ohr Pharmaceutical (ticker: OHRP) initiating their planned Phase 2 trial in Wet-AMD

Algae.Tec providing an update on their showcase biofuels facility Shoalhaven One in Nowra Australia

Acorn Energy (ticker: ACFN) announcing additional orders from their portfolio of companies that are addressing the needs of our existing energy infrastructure through their respective innovative technologies

Auxilio (ticker: AUXO) continuing to win new hospital clients

The Companies featured in the FREE August Newsletter are: Acorn Energy, Inc. (ticker: ACFN), ADVENTRX Pharmaceuticals, Inc. (ticker: ANX), Algae.Tec Limited, Auxilio Inc. (ticker: AUXO), Ohr Pharmaceutical, Inc. (ticker: OHRP), OncoSec Medical Inc. and PositiveID Corporation. Other Companies mentioned are Roche, Regeneron, Pfizer, Facebook, and Lufthansa.

To download the FREE August Newsletter, please visit and click the "download newsletter" icon to gain access.





About Vista Partners:
Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista Partners LLC has built a name for itself in the small cap space due to its selection of .



Disclaimer & Disclosure:
We encourage readers to view a complete list of disclaimers and disclosures on our website: .





Contact:
Vista Partners LLC
877.215.4813


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Methanex to Present at Jefferies 2012 Global Industrial and A&D Conference
Agrium Agrees to Sale of Minority Interest in Medicine Hat Nitrogen Facility and Announces $900-Million Substantial Issuer Bid to Repurchase Shares
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 02.08.2012 - 07:15 Uhr
Sprache: Deutsch
News-ID 1138967
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SAN FRANCISCO, CA


Phone:

Kategorie:

Commodity Chemicals


Anmerkungen:


Diese Pressemitteilung wurde bisher 305 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Vista Partners Publishes August 2012 Newsletter
"
steht unter der journalistisch-redaktionellen Verantwortung von

Vista Partners LLC (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Vista Partners LLC



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 2
Members online: 1
Guests online: 103


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.